The effect of tiotropium/olodaterol versus tiotropium on COPD exacerbation rates in patients with/without frequent exacerbation history

27 Jun 2020
pdf
Abstract - The effect of tiotropium/olodaterol versus tiotropium on COPD exacerbation rates in patients with/without frequent ex
225.15 KB
pdf
Presentation- The effect of tiotropium/olodaterol versus tiotropium on COPD exacerbation rates in patients with/without frequent
777.81 KB

Resource information

Respiratory conditions
  • COPD
Type of resource
Abstract
Author(s)
Jadwiga Wedzicha1, Roland Buhl2, Alberto de la Hoz3, Florian Voß4, Peter M.A. Calverley5 1Respiratory Division, National Heart and Lung Institute, Imperial College London, London, UK, 2Johannes Gutenberg University Mainz, Mainz, Germany, 3Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany, 4Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany, 5Clinical Science Centre, Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, UK